Engineers Gate Manager LP Acelrx Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.2 - $0.35 $14,378 - $25,162	-71,893 Reduced 55.0%	58,823 $12,000
Q1 2022 May 16, 2022	SELL	$0.28 - $0.61 $7,562 - $16,475	-27,009 Reduced 17.12%	130,716 $37,000
Q4 2021 Feb 14, 2022	BUY	$0.49 - $1.02 $6,080 - $12,658	12,410 Added 8.54%	157,725 $88,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.51 $41,757 - $67,799	-44,900 Reduced 23.6%	145,315 $148,000
Q2 2021 Aug 16, 2021	SELL	$1.03 - $1.7 $53,188 - $87,786	-51,639 Reduced 21.35%	190,215 $262,000
Q1 2021 May 17, 2021	BUY	$1.25 - $2.77 $302,317 - $669,935	241,854 New	241,854 $411,000
Q1 2019 May 15, 2019	SELL	$2.35 - $3.83 $401,380 - $654,164	-170,800 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $363,804 - $819,840	170,800 New	170,800 $395,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.